Common Problems with Semaglutide and How to Handle Them

Which problems with semaglutide are genuinely common?

The side-effect profile is well established across large clinical programmes. Nausea sits at the top of the list, most people on semaglutide experience it to some degree, especially in the first few weeks or after stepping up to a higher dose. Diarrhoea and constipation can both appear, sometimes alternating, along with indigestion, belching, and a general sense of sluggishness after eating. Fatigue and mild headaches are also reported, though these tend to be short-lived.

The NHS medicines page for semaglutide lists these effects clearly, and the clinical trial data reflects them: in the OASIS 4 trial of the oral formulation, 74% of participants on semaglutide reported gastrointestinal effects versus 42% on placebo, mostly mild to moderate and transient. The injection programme tells a similar story. What matters is that most of these problems peak around a dose increase, then ease as your body adjusts. A useful one-minute check: look at your injection diary and note when the symptom started relative to your last dose change. If it appeared within a day or two of stepping up, that is the pattern you would expect.

Injection-site reactions (redness, a small lump, brief discomfort) are also common and rarely significant. Rotating sites between your abdomen, thigh and upper arm helps keep them manageable. The full picture of semaglutide's stomach-related effects is worth reading if GI symptoms are your main concern.

When do problems with Wegovy need more than self-management?

Most semaglutide problems can be navigated with practical adjustments, but some symptoms cross a line that warrants same-day contact with a clinician or, in urgent cases, A&E. Severe, persistent stomach pain that radiates to the back (with or without vomiting) is the key warning sign for acute pancreatitis, a recognised but infrequent side effect of GLP-1 medicines. The MHRA highlighted this risk in a Drug Safety Update in January 2026, advising patients to seek urgent help immediately rather than waiting to see if it passes.

Gallbladder problems are another category to take seriously: sudden sharp pain in the upper-right abdomen, particularly after eating fatty food, can signal gallstones or inflammation. Significant dehydration from prolonged vomiting or diarrhoea puts extra strain on the kidneys, so if you cannot keep fluids down for more than 24 hours, get medical advice that day.

Vision changes also deserve attention. Semaglutide has been associated with a rare condition affecting the optic nerve, and any sudden or unexplained change in your sight should be assessed promptly. There is a detailed guide to Wegovy and eyesight problems if you want to understand that risk more fully. You can report any suspected side effect directly to the MHRA via the Yellow Card scheme, a step that benefits everyone on these medicines, not just you.

Do problems with semaglutide mean you should stop taking it?

Not necessarily, and stopping without speaking to your prescriber is rarely the right move. Unilaterally skipping doses or abandoning treatment means losing the appetite-regulating effect and can make the next attempt harder. There are better options. If nausea is significant, smaller, blander meals and avoiding lying down after eating make a real difference for many people. Eating more slowly, keeping portions modest, and cutting back on alcohol and rich food (particularly around injection day) are adjustments that regularly help.

If problems persist beyond a couple of weeks at a stable dose, or if they are affecting your quality of life, the conversation to have is with your prescriber about whether to slow the titration schedule, staying longer at the current dose rather than moving up. This is a recognised clinical strategy, not a failure. For a broader look at what semaglutide treatment involves, the weight-loss treatment overview covers how these medicines fit into a wider approach to managing weight.

Sleep disruption is a less-discussed concern that does come up. If you notice changes to your sleep pattern after starting or increasing your dose, it is worth mentioning to your prescriber; there is more on the topic at whether Wegovy can cause sleep problems. The cost of ongoing treatment is a practical consideration too, the Wegovy cost context page sets out what affects pricing in the UK private market.

What should you tell your prescriber about ongoing problems?

Prescribers make better decisions with specific information. Before you contact your clinical team, it helps to note the symptom, when it started relative to your last dose change, how long it has lasted, and whether anything makes it better or worse. That takes about a minute and means the conversation is far more productive.

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before dispatch, a real clinician reads your update, not a script. If you are experiencing ongoing problems with semaglutide or Wegovy, that review is the place to raise them. You can also reach our team directly via our contact page for aftercare queries seven days a week. If you have not yet started treatment and want to understand whether semaglutide is clinically appropriate for you, speak to our prescribers through a free consultation, there is no obligation and no charge for the assessment.